119 related articles for article (PubMed ID: 11781825)
21. Thermodynamics of b-HLH-LZ protein binding to DNA: the energetic importance of protein-DNA contacts in site-specific E-box recognition by the complete gene product of the Max p21 transcription factor.
Meier-Andrejszki L; Bjelić S; Naud JF; Lavigne P; Jelesarov I
Biochemistry; 2007 Oct; 46(43):12427-40. PubMed ID: 17915948
[TBL] [Abstract][Full Text] [Related]
22. The N-myc oncoprotein is a transcriptional activator and associates with max and RB1 proteins.
Wenzel A; Cziepluch C; Schürmann J; Schwab M
Prog Clin Biol Res; 1994; 385():59-66. PubMed ID: 7972238
[No Abstract] [Full Text] [Related]
23. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
24. The transcription activation domains of v-Myc and VP16 interact with common factors required for cellular transformation and proliferation.
Min S; Crider-Miller SJ; Taparowsky EJ
Cell Growth Differ; 1994 Jun; 5(6):563-73. PubMed ID: 8086335
[TBL] [Abstract][Full Text] [Related]
25. Spatial and temporal expression of the myometrial mitogen-activated protein kinases p38 and ERK1/2 in the human uterus during pregnancy and labor.
Otun HA; MacDougall MW; Bailey J; Europe-Finner GN; Robson SC
J Soc Gynecol Investig; 2005 Apr; 12(3):185-90. PubMed ID: 15784503
[TBL] [Abstract][Full Text] [Related]
26. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
[TBL] [Abstract][Full Text] [Related]
27. v-Myc inhibits C/EBPbeta activity by preventing C/EBPbeta-induced phosphorylation of the co-activator p300.
Steinmann S; Schulte K; Beck K; Chachra S; Bujnicki T; Klempnauer KH
Oncogene; 2009 Jul; 28(26):2446-55. PubMed ID: 19448669
[TBL] [Abstract][Full Text] [Related]
28. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
Soucek L; Jucker R; Panacchia L; Ricordy R; Tatò F; Nasi S
Cancer Res; 2002 Jun; 62(12):3507-10. PubMed ID: 12067996
[TBL] [Abstract][Full Text] [Related]
29. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M
Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761
[TBL] [Abstract][Full Text] [Related]
30. Competitive binding of CREB and ATF2 to cAMP/ATF responsive element regulates eNOS gene expression in endothelial cells.
Niwano K; Arai M; Koitabashi N; Hara S; Watanabe A; Sekiguchi K; Tanaka T; Iso T; Kurabayashi M
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1036-42. PubMed ID: 16497991
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of TRRAP-dependent hTERT and TRRAP-independent CAD activation by Myc/Max contributes to the differentiation of HL60 cells after exposure to DMSO.
Jiang G; Bi K; Tang T; Wang J; Zhang Y; Zhang W; Ren H; Bai H; Wang Y
Int Immunopharmacol; 2006 Jul; 6(7):1204-13. PubMed ID: 16714225
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
[TBL] [Abstract][Full Text] [Related]
33. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
34. Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK.
Sevilla A; Santos CR; Vega FM; Lazo PA
J Biol Chem; 2004 Jun; 279(26):27458-65. PubMed ID: 15105425
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of the N-terminal domain of the Myc oncoprotein.
Oster SK; Mao DY; Kennedy J; Penn LZ
Oncogene; 2003 Apr; 22(13):1998-2010. PubMed ID: 12673205
[TBL] [Abstract][Full Text] [Related]
36. Characterization and functional analysis of cAMP response element modulator protein and activating transcription factor 2 (ATF2) isoforms in the human myometrium during pregnancy and labor: identification of a novel ATF2 species with potent transactivation properties.
Bailey J; Phillips RJ; Pollard AJ; Gilmore K; Robson SC; Europe-Finner GN
J Clin Endocrinol Metab; 2002 Apr; 87(4):1717-28. PubMed ID: 11932306
[TBL] [Abstract][Full Text] [Related]
37. AR suppresses transcription of the alpha glycoprotein hormone subunit gene through protein-protein interactions with cJun and activation transcription factor 2.
Jorgensen JS; Nilson JH
Mol Endocrinol; 2001 Sep; 15(9):1496-504. PubMed ID: 11518798
[TBL] [Abstract][Full Text] [Related]
38. Protein stabilization: a common consequence of mutations in independently derived v-Myc alleles.
Gavine PR; Neil JC; Crouch DH
Oncogene; 1999 Dec; 18(52):7552-8. PubMed ID: 10602514
[TBL] [Abstract][Full Text] [Related]
39. TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage.
Cho SG; Bhoumik A; Broday L; Ivanov V; Rosenstein B; Ronai Z
Mol Cell Biol; 2001 Dec; 21(24):8398-413. PubMed ID: 11713276
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitination and degradation of ATF2 are dimerization dependent.
Fuchs SY; Ronai Z
Mol Cell Biol; 1999 May; 19(5):3289-98. PubMed ID: 10207054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
